Drugs / Δ9-tetrahydrocannabinol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03471585 | Feb → Oct 2017 | — | University of Chicago | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Δ9-tetrahydrocannabinol | “We investigated the impact of the administration of Δ9-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, on a context-based memory illusion.” PMID 31668830 ↗ Aug 2019 |
| Known as | THC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03471585 ↗ |
| Route | Oral | “THC (15 mg oral)” PMID 31668830 ↗ Aug 2019 |